Arcadia Biosciences (RKDA) Operating Income (2014 - 2025)

Arcadia Biosciences has reported Operating Income for 12 years, with the latest figure at $634000.0 in Q4 2025.

• For the quarter ending Q4 2025, Operating Income rose 692.52% year-over-year to $634000.0; the trailing twelve-month figure through Dec 2025 stood at -$489000.0 (up 66.85% YoY), and the FY2025 full-year result was -$491000.0, up 66.73% from the prior year.
• Operating Income for Q4 2025 stood at $634000.0, up from -$1.2 million in the prior quarter.
• The five-year high for Operating Income was $5.6 million in Q4 2021, with the low at -$5.4 million in Q2 2021.
• Historically, Operating Income has averaged -$1.7 million across 5 years, with a median of -$1.5 million in 2023.
• Annual changes were most pronounced in 2021 — Operating Income slumped 318.28% — and 2025, when it surged 692.52%.
• Arcadia Biosciences' Operating Income stood at $5.6 million in 2021, then plunged by 183.33% to -$4.7 million in 2022, then soared by 74.39% to -$1.2 million in 2023, then jumped by 91.03% to -$107000.0 in 2024, then surged by 692.52% to $634000.0 in 2025.
• The last three Operating Income figures came in at $634000.0 (Q4 2025), -$1.2 million (Q3 2025), and -$501000.0 (Q2 2025), per Business Quant data.